Fortitude Family Office’s Tonix Pharmaceuticals TNXP Stock Holding History

Fortitude Family Office’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.44K	Buy	+113	New	+$1.46K	﹤0.01%	1614

Other funds holding TNXP

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Cornerstone National Bank & Trust Palatine, Illinois $296M AUM 12.13% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Fortitude Family Office's TNXP Position: Q2 2026 in Review

Fortitude Family Office opened a new position in Tonix Pharmaceuticals (TNXP) in Q2 2026: 113 shares worth $1.44K. The stake represents ﹤0.01% of the portfolio and ranks #1614 among its holdings.

14 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

Fortitude Family Office held 113 shares of Tonix Pharmaceuticals worth $1.44K as of Q2 2026.
Tonix Pharmaceuticals was a new Fortitude Family Office position in Q2 2026.
Tonix Pharmaceuticals made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1614 holding.
14 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.